Objective: To investigate the relationship between the plasma microRNA(miRNA)-146a expression, gene hypermethylation and the disease activity in patients with rheumatoid arthritis(RA). Methods: From March 2019 to April 2020, 122 RA patients were recruited into RA group in the rheumatology department of our hospital. The disease activity was measured using the 28-joint disease activity score obtained on the basis of erythrocyte sedimentation rate(ESR) (DAS28-ESR). During the same period, another 141 healthy volunteers were included as control group. The plasma miR-146a level was detected by real-time fluorescence quantitative PCR,and the methylation status was analyzed by real-time fluorescence quantitative methylation specific PCR(qMSP). Results: The plasma miR-146a level in the RA group was significantly higher than that in the control group, and the methylation level of miR-146a gene was significantly lower than that in the control group(P<0.05). Plasma miR-146a level was negatively correlated with miR-146a gene methylation level(P<0.05). With the increase of disease activity, the plasma level of miR-146a increased and the methylation level of miR-146a gene decreased(P<0.05). The plasma miR-146a level was positively correlated with DAS28-ESR, ESR, C-reactive protein, joint swelling count, joint tenderness count, patients' subjective global assessment, physician's global assessment and simplified disease activity index(P<0.05). The methylation level of miR-146a gene was negatively correlated with the above indexes(P<0.05). Conclusion: Plasma miR-146a and gene methylation status are related to the degree of disease activity in RA patients and may be potential markers for the diagnosis and control of RA disease activity. |
[1] 段毅,易谭勇,朱乐全,等.LncRNA MEG3调控miR-328影响类风湿性关节炎滑膜细胞增殖、凋亡和炎性反应[J].中国组织化学与细胞化学杂志,2021,30(2):136-145.
[2] 郭淑芳,姜婷婷.下调miR-217抑制类风湿性关节炎患者外周血单个核细胞炎症反应的实验研究[J].中国免疫学杂志,2020,36(8):933-938.
[3] PAYET M,DARGAI F,GASQUE P,et al.Epigenetic regulation(including micro-RNAs,DNA methylation and histone modifications) of rheumatoid arthritis:a systematic review[J].Int J Mol Sci,2021,22(22):12170-12187.
[4] 朱嘉豪,陈婷,习欠云.miR-146a参与不同疾病的研究进展[J].中国生物工程杂志,2021,41(9):64-70.
[5] 胡钰镔,陈德丽,施月娟,等.外周血单个核细胞miR-146a和微管相关蛋白1轻链3及红细胞沉降率与类风湿关节炎疾病活动的关系[J].中华实用诊断与治疗杂志,2022,36(1):68-71.
[6] BAE S C,LEE Y H.MiR-146a levels in rheumatoid arthritis and their correlation with disease activity:a meta-analysis[J].Int J Rheum Dis,2018,21(7):1335-1342.
[7] ZHAO J,CHEN B,PENG X,et al.Quercetin suppresses migration and invasion by targeting miR-146a/GATA6 axis in fibroblast-like synoviocytes of rheumatoid arthritis[J].Immunopharmacol Immunotoxicol,2020,42(3):221-227.
[8] PAPATHANASIOU I,TRACHANA V,MOURMOURA E,et al.DNA methylation regulates miR-140-5p and miR-146a expression in osteoarthritis[J].Life Sci,2019,228:274-284.
[9] 魏亭亭,秦苇,冯伟伟,等.类风湿关节炎患者疲劳程度与疾病活动度的关系[J].浙江医学,2021,43(16):1781-1784.
[10] KOLARZ B,CIESLA M,DRYGLEWSKA M,et al.Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis[J].PLoS One,2020,15(6):e0233897.
[11] FUNES S C,FERNANDEZ-FIERRO A,REBOLLEDO-ZELADA D,et al.Contribution of dysregulated DNA methylation to autoimmunity[J].Int J Mol Sci,2021,22(21):11892-11911.
[12] IACONA J R,MONTELEONE N J,LUTZ C S.miR-146a suppresses 5-lipoxygenase activating protein(FLAP) expression and Leukotriene B4 production in lung cancer cells[J].Oncotarget,2018,9(42):26751-26769.
[13] BAGHERI-HOSSEINABADI Z,MIRZAEI M R,HAJIZADEH M R,et al.Plasma microRNAs(miR-146a,miR-103a,and miR-155) as potential biomarkers for rheumatoid arthritis(RA) and disease activity in Iranian patients[J].Mediterr J Rheumatol,2021,32(4):324-330.
[14] KMIOLEK T,RZESZOTARSKA E,WAJDA A,et al.The interplay between transcriptional factors and microRNAs as an important factor for Th17/Treg balance in RA patients[J].Int J Mol Sci,2020,21(19):7169-7186.
[15] ERFAN R,SHAKER O G,KHALIL M A F,et al.Long non-coding RNA PVT1 and its target miRNA-146a as potential prognostic biomarkers in rheumatoid arthritis patients[J].Life(Basel),2021,11(12):1382-1395. |